Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AAV2-hAADC in AADC deficiency
NCT01395641Phase 2Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Oct 2014
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Phase 2, open-label trial of eladocagene exuparvovec in Aromatic L-amino acid decarboxylase deficiency (AADC), sponsored by National Taiwan University Hospital. Primary endpoint: Evaluation of therapeutic effect at 12 months. Started Oct 2014; status: completed.
02
Drugs
eladocagene exuparvovec
03
Conditions
Aromatic L-amino acid decarboxylase deficiency (AADC)
Beyond the preview
Go deeper on NCT01395641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01395641.